In NASH-HCC models, lack of FGF21 caused significant upregulation of the hepatocyte-derived IL-17A via TLR4 and NF-κB signaling, which suggests that FGF21 and NF-κB may be involved in the transition of NASH-HCC. This evidence concerns the gene IL17A and metabolic dysfunction-associated steatohepatitis.